Potential use of cassava bioethanol waste as ruminant feed in fermented total mixed ration: In vitro trial
Asian Journal of Agriculture and Biology · 07.06.2026
DOI: 10.35495/ajab.2026.054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Agriculture and Biology, online erschienen am 07.06.2026. Verfasst von Ruangyote Pilajun.
Abstract (Originalsprache)
This study identified the optimal inclusion levels of fresh cassava bioethanol waste (CBW) as well as the most effective additive types based on physical properties, chemical composition, and in vitro ruminal fermentation characteristics.The experiment used a 4x4 factorial arrangement in a CRD with four CBW levels (0, 5, 10, and 15% dry matter (DM)) as well as four additive treatments (none, dry yeast, probiotics, and non-starch polysaccharides (NSP) enzymes) in fermented total mixed rations (FTMR).FTMR was ensiled for 21 days before being evaluated.Interactions between CBW levels and additives significantly affected physical scores, chemical composition, and fermentation end-products (P 0.05).The addition of dry yeast increased the gas produced from the immediately soluble fraction (b) and the potential extent of gas production (P).NSP enzyme increased cumulative gas volume at 72 and 96 hours after incubation as well as the gas produced from the immediately soluble fraction (P
Zitieren
APA
Pilajun, R. (2026). Potential use of cassava bioethanol waste as ruminant feed in fermented total mixed ration: In vitro trial. Asian Journal of Agriculture and Biology. https://doi.org/10.35495/ajab.2026.054
Vancouver
Pilajun R. Potential use of cassava bioethanol waste as ruminant feed in fermented total mixed ration: In vitro trial. Asian Journal of Agriculture and Biology. 2026. doi:10.35495/ajab.2026.054
BibTeX
@article{Pilajun2026,
author = {Pilajun, Ruangyote},
title = {Potential use of cassava bioethanol waste as ruminant feed in fermented total mixed ration: In vitro trial},
journal = {Asian Journal of Agriculture and Biology},
year = {2026},
doi = {10.35495/ajab.2026.054}
}
EUVIMED